{"id":"https://openalex.org/W2157692941","doi":"https://doi.org/10.1128/aac.00329-09","title":"Combination Therapy in Treatment of Experimental Pulmonary Aspergillosis: In Vitro and In Vivo Correlations of the Concentration- and Dose- Dependent Interactions between Anidulafungin and Voriconazole by Bliss Independence Drug Interaction Analysis","display_name":"Combination Therapy in Treatment of Experimental Pulmonary Aspergillosis: In Vitro and In Vivo Correlations of the Concentration- and Dose- Dependent Interactions between Anidulafungin and Voriconazole by Bliss Independence Drug Interaction Analysis","alternate_titles":[],"publication_year":2009,"publication_date":"2009-03-24","ids":{"openalex":"https://openalex.org/W2157692941","doi":"https://doi.org/10.1128/aac.00329-09","mag":"2157692941","pmid":"https://pubmed.ncbi.nlm.nih.gov/19307368","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2687223"},"language":"en","primary_location":{"id":"doi:10.1128/aac.00329-09","doi":"https://doi.org/10.1128/aac.00329-09","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.00329-09","pdf_url":"https://aac.asm.org/content/aac/53/6/2382.full.pdf","source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2157692941"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://aac.asm.org/content/aac/53/6/2382.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073959865","display_name":"Vidmantas Petraitis","orcid":"https://orcid.org/0000-0001-6811-4467","observed_orcids":["https://orcid.org/0000-0001-6811-4467"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I880747138","display_name":"Science Applications International Corporation (United States)","ror":"https://ror.org/00zv91802","country_code":"US","type":"company","lineage":["https://openalex.org/I880747138"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vidmantas Petraitis","raw_affiliation_strings":["Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland","Laboratory Animal Sciences Program, SAIC-Frederick, Inc., Frederick, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland","institution_ids":["https://openalex.org/I4210140884"]},{"raw_affiliation_string":"Laboratory Animal Sciences Program, SAIC-Frederick, Inc., Frederick, Maryland","institution_ids":["https://openalex.org/I880747138"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062858475","display_name":"R\u016bta Petraitien\u0117","orcid":"https://orcid.org/0000-0002-3269-8058","observed_orcids":["https://orcid.org/0000-0002-3269-8058"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I880747138","display_name":"Science Applications International Corporation (United States)","ror":"https://ror.org/00zv91802","country_code":"US","type":"company","lineage":["https://openalex.org/I880747138"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ruta Petraitiene","raw_affiliation_strings":["Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland","Laboratory Animal Sciences Program, SAIC-Frederick, Inc., Frederick, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland","institution_ids":["https://openalex.org/I4210140884"]},{"raw_affiliation_string":"Laboratory Animal Sciences Program, SAIC-Frederick, Inc., Frederick, Maryland","institution_ids":["https://openalex.org/I880747138"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057302419","display_name":"William W. Hope","orcid":"https://orcid.org/0000-0001-6187-878X","observed_orcids":["https://orcid.org/0000-0001-6187-878X"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William W. Hope","raw_affiliation_strings":["Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047745235","display_name":"Joseph Meletiadis","orcid":"https://orcid.org/0000-0002-8869-1509","observed_orcids":["https://orcid.org/0000-0002-8869-1509"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph Meletiadis","raw_affiliation_strings":["Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024612674","display_name":"Diana Mickiene","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I880747138","display_name":"Science Applications International Corporation (United States)","ror":"https://ror.org/00zv91802","country_code":"US","type":"company","lineage":["https://openalex.org/I880747138"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Diana Mickiene","raw_affiliation_strings":["Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland","Laboratory Animal Sciences Program, SAIC-Frederick, Inc., Frederick, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland","institution_ids":["https://openalex.org/I4210140884"]},{"raw_affiliation_string":"Laboratory Animal Sciences Program, SAIC-Frederick, Inc., Frederick, Maryland","institution_ids":["https://openalex.org/I880747138"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025101258","display_name":"Johanna E. Hughes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Johanna E. Hughes","raw_affiliation_strings":["Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024740943","display_name":"Margaret P. Cotton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Margaret P. Cotton","raw_affiliation_strings":["Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066839378","display_name":"Theodouli Stergiopoulou","orcid":"https://orcid.org/0000-0003-0124-6582","observed_orcids":["https://orcid.org/0000-0003-0124-6582"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Theodouli Stergiopoulou","raw_affiliation_strings":["Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014710077","display_name":"Miki Kasai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Miki Kasai","raw_affiliation_strings":["Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Andrea Francesconi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrea Francesconi","raw_affiliation_strings":["Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040164919","display_name":"Robert L. Schaufele","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert L. Schaufele","raw_affiliation_strings":["Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054425270","display_name":"Tin Sein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I880747138","display_name":"Science Applications International Corporation (United States)","ror":"https://ror.org/00zv91802","country_code":"US","type":"company","lineage":["https://openalex.org/I880747138"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tin Sein","raw_affiliation_strings":["Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland","Laboratory Animal Sciences Program, SAIC-Frederick, Inc., Frederick, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland","institution_ids":["https://openalex.org/I4210140884"]},{"raw_affiliation_string":"Laboratory Animal Sciences Program, SAIC-Frederick, Inc., Frederick, Maryland","institution_ids":["https://openalex.org/I880747138"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112263701","display_name":"Nilo A. Avila","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210155647","display_name":"National Institutes of Health Clinical Center","ror":"https://ror.org/04vfsmv21","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210155647"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nilo A. Avila","raw_affiliation_strings":["Department of Radiology, Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiology, Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210155647"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109136757","display_name":"John D Bacher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210127607","display_name":"Office of Research Services","ror":"https://ror.org/02yrzyf97","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210091794","https://openalex.org/I4210127607"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Bacher","raw_affiliation_strings":["Surgery Service, Veterinary Resources Program, Office of Research Services, National Institutes of Health, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Surgery Service, Veterinary Resources Program, Office of Research Services, National Institutes of Health, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210127607"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071800632","display_name":"Thomas J. Walsh","orcid":"https://orcid.org/0000-0002-4142-8711","observed_orcids":["https://orcid.org/0000-0002-4142-8711"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Thomas J. Walsh","raw_affiliation_strings":["Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland","institution_ids":["https://openalex.org/I4210140884"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5071800632"],"corresponding_institution_ids":["https://openalex.org/I4210140884"],"apc_list":null,"apc_paid":null,"fwci":7.3874,"has_fulltext":true,"cited_by_count":106,"citation_normalized_percentile":{"value":0.97448572,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"53","issue":"6","first_page":"2382","last_page":"2391"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10497","display_name":"Fungal and yeast genetics research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anidulafungin","display_name":"anidulafungin","score":0.9089999794960022},{"id":"https://openalex.org/keywords/voriconazole","display_name":"voriconazole","score":1.0},{"id":"https://openalex.org/keywords/combination-antifungal-therapy","display_name":"combination antifungal therapy","score":0.8870000243186951},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.5929999947547913},{"id":"https://openalex.org/keywords/synergistic-effect","display_name":"synergistic effect","score":0.5720000267028809},{"id":"https://openalex.org/keywords/antagonism","display_name":"antagonism","score":0.8420000076293945},{"id":"https://openalex.org/keywords/echinocandins","display_name":"echinocandins","score":0.8009999990463257},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.6430000066757202},{"id":"https://openalex.org/keywords/rabbit-model","display_name":"rabbit model","score":0.5950000286102295},{"id":"https://openalex.org/keywords/antifungal-susceptibility","display_name":"antifungal susceptibility","score":0.5590000152587891},{"id":"https://openalex.org/keywords/galactomannan","display_name":"galactomannan","score":0.8019999861717224},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.3880000114440918},{"id":"https://openalex.org/keywords/dose-dependent-effects","display_name":"dose-dependent effects","score":0.453000009059906},{"id":"https://openalex.org/keywords/in-vitro-in-vivo-correlation","display_name":"in vitro-in vivo correlation","score":0.8479999899864197},{"id":"https://openalex.org/keywords/invasive-aspergillosis","display_name":"invasive aspergillosis","score":0.6230000257492065}],"concepts":[{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5239952802658081},{"id":"https://openalex.org/C2780690907","wikidata":"https://www.wikidata.org/wiki/Q412236","display_name":"Voriconazole","level":3,"score":0.5004019737243652},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.46175122261047363},{"id":"https://openalex.org/C2779629538","wikidata":"https://www.wikidata.org/wiki/Q412223","display_name":"Amphotericin B","level":3,"score":0.43379196524620056},{"id":"https://openalex.org/C2776222947","wikidata":"https://www.wikidata.org/wiki/Q4764531","display_name":"Anidulafungin","level":5,"score":0.42052337527275085},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37640151381492615},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3700571060180664},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3628576397895813},{"id":"https://openalex.org/C2779548794","wikidata":"https://www.wikidata.org/wiki/Q578726","display_name":"Antifungal","level":2,"score":0.19928795099258423},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.13606935739517212},{"id":"https://openalex.org/C2780402444","wikidata":"https://www.wikidata.org/wiki/Q420875","display_name":"Caspofungin","level":4,"score":0.08635663986206055},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.07411572337150574}],"mesh":[{"descriptor_ui":"D000077612","descriptor_name":"Anidulafungin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001992","descriptor_name":"Bronchoalveolar Lavage Fluid","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005690","descriptor_name":"Galactose","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008351","descriptor_name":"Mannans","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D008351","descriptor_name":"Mannans","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D011817","descriptor_name":"Rabbits","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054714","descriptor_name":"Echinocandins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D054714","descriptor_name":"Echinocandins","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D054714","descriptor_name":"Echinocandins","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D055732","descriptor_name":"Pulmonary Aspergillosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D055732","descriptor_name":"Pulmonary Aspergillosis","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D065819","descriptor_name":"Voriconazole","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1128/aac.00329-09","doi":"https://doi.org/10.1128/aac.00329-09","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.00329-09","pdf_url":"https://aac.asm.org/content/aac/53/6/2382.full.pdf","source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:1855612","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2687223","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:19307368","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19307368","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial agents and chemotherapy","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2687223","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2687223/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/2780caf8-d4ec-48f5-bb3e-a88c00e48e1e","doi":null,"is_oa":false,"landing_page_url":"https://research.manchester.ac.uk/en/publications/2780caf8-d4ec-48f5-bb3e-a88c00e48e1e","pdf_url":null,"source":{"id":"https://openalex.org/S4306400662","display_name":"Research Explorer (The University of Manchester)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I28407311","host_organization_name":"University of Manchester","host_organization_lineage":["https://openalex.org/I28407311"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:orbi.ulg.ac.be:2268/249616","doi":null,"is_oa":true,"landing_page_url":"https://orbi.uliege.be/handle/2268/249616","pdf_url":null,"source":{"id":"https://openalex.org/S4306401300","display_name":"ORBi (University of Li\u00e8ge)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I157674565","host_organization_name":"University of Li\u00e8ge","host_organization_lineage":["https://openalex.org/I157674565"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Antimicrobial Agents and Chemotherapy, 53 (6), 2382-91 (2009-06)","raw_type":"http://purl.org/coar/resource_type/c_6501"}],"best_oa_location":{"id":"doi:10.1128/aac.00329-09","doi":"https://doi.org/10.1128/aac.00329-09","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.00329-09","pdf_url":"https://aac.asm.org/content/aac/53/6/2382.full.pdf","source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2157692941.pdf","grobid_xml":"https://content.openalex.org/works/W2157692941.grobid-xml"},"referenced_works_count":41,"referenced_works":["https://openalex.org/W391620583","https://openalex.org/W1575274098","https://openalex.org/W1581962345","https://openalex.org/W1915036617","https://openalex.org/W1923850605","https://openalex.org/W1998801028","https://openalex.org/W2012447490","https://openalex.org/W2014907435","https://openalex.org/W2039366893","https://openalex.org/W2045138757","https://openalex.org/W2054771967","https://openalex.org/W2057018930","https://openalex.org/W2064024882","https://openalex.org/W2089895563","https://openalex.org/W2091637502","https://openalex.org/W2098898162","https://openalex.org/W2099140379","https://openalex.org/W2103659147","https://openalex.org/W2106072878","https://openalex.org/W2106080885","https://openalex.org/W2108740197","https://openalex.org/W2108801883","https://openalex.org/W2115984022","https://openalex.org/W2127806652","https://openalex.org/W2129942501","https://openalex.org/W2130173410","https://openalex.org/W2131100764","https://openalex.org/W2134986902","https://openalex.org/W2136148468","https://openalex.org/W2141395083","https://openalex.org/W2142632979","https://openalex.org/W2149288225","https://openalex.org/W2150146664","https://openalex.org/W2153911335","https://openalex.org/W2168578345","https://openalex.org/W2169811240","https://openalex.org/W2266208874","https://openalex.org/W2321413400","https://openalex.org/W2338427714","https://openalex.org/W2565410782","https://openalex.org/W2955504961"],"related_works":["https://openalex.org/W2107225499","https://openalex.org/W2040434975","https://openalex.org/W2001970376","https://openalex.org/W1972380082","https://openalex.org/W2505435473","https://openalex.org/W2099140379","https://openalex.org/W2137149687","https://openalex.org/W2464111769","https://openalex.org/W2169811240"],"abstract_inverted_index":{"We":[0,238],"studied":[1],"the":[2,26,84,89,94,99,104,109,208,235,241,290],"antifungal":[3],"activity":[4],"of":[5,43,56,125,170,243,249,263,283],"anidulafungin":[6],"(AFG)":[7],"in":[8,19,27,30,141,166,181,190,223,247,252],"combination":[9,242],"with":[10,147,196,245],"voriconazole":[11],"(VRC)":[12],"against":[13],"experimental":[14,250],"invasive":[15],"pulmonary":[16,127],"aspergillosis":[17],"(IPA)":[18],"persistently":[20,253],"neutropenic":[21,254],"rabbits":[22,116,143,255],"and":[23,29,51,73,79,112,138,149,163,194,221,230],"further":[24],"explored":[25],"vitro":[28],"vivo":[31,191],"correlations":[32],"by":[33,130,275],"using":[34],"Bliss":[35,186,276],"independence":[36,229,277],"drug":[37],"interaction":[38],"analysis.":[39],"Treatment":[40],"groups":[41],"consisted":[42],"those":[44,145,169],"receiving":[45],"AFG":[46,220,244],"at":[47,60,260,270],"5":[48,264],"(AFG5":[49],"group)":[50,54,78],"10":[52,61,271],"(AFG10":[53],"mg/kg":[55,62],"body":[57],"weight/day,":[58],"VRC":[59,70,76,95,150,222,246],"every":[63],"8":[64],"h":[65],"(VRC":[66],"group),":[67,72],"AFG5":[68,105,148,193],"plus":[69,75],"(AFG5+VRC":[71],"AFG10":[74,110],"(AFG10+VRC":[77],"untreated":[80],"controls.":[81],"Survival":[82],"throughout":[83],"study":[85],"was":[86,121,188,256],"60%":[87],"for":[88,93,98,103,108,114,226],"AFG5+VRC":[90],"group,":[91,96,101,106,111],"50%":[92],"27%":[97],"AFG10+VRC":[100,157,176],"22%":[102],"18%":[107],"0%":[113],"control":[115],"(P":[117,152,173],"<":[118,153,174],"0.001).":[119],"There":[120],"a":[122,261],"significant":[123,179],"reduction":[124],"organism-mediated":[126],"injury,":[128],"measured":[129],"infarct":[131,161],"scores,":[132],"lung":[133,164],"weights,":[134],"residual":[135],"fungal":[136],"burdens,":[137],"galactomannan":[139],"indexes,":[140],"AFG5+VRC-treated":[142],"versus":[144],"treated":[146],"alone":[151],"0.05).":[154,175],"In":[155],"comparison,":[156],"significantly":[158],"lowered":[159],"only":[160,228],"scores":[162],"weights":[165],"comparison":[167],"to":[168,201,258,268,289],"AFG10-treated":[171],"animals":[172],"showed":[177],"no":[178],"difference":[180],"other":[182],"outcome":[183,236],"variables.":[184,237],"Significant":[185],"synergy":[187],"found":[189,218],"between":[192,219],"VRC,":[195],"observed":[197,233],"effects":[198],"being":[199],"24":[200],"30%":[202],"higher":[203,281],"than":[204],"expected":[205],"levels":[206],"if":[207],"drugs":[209],"were":[210,216,232],"acting":[211],"independently.":[212],"These":[213],"synergistic":[214,259],"interactions":[215],"also":[217],"vitro.":[224],"However,":[225],"AFG10+VRC,":[227],"antagonism":[231],"among":[234],"concluded":[239],"that":[240,280],"treatment":[248],"IPA":[251],"independent":[257,267],"dosage":[262],"mg/kg/day":[265],"but":[266],"antagonistic":[269],"mg/kg/day,":[272],"as":[273],"assessed":[274],"analysis,":[278],"suggesting":[279],"dosages":[282],"an":[284],"echinocandin":[285],"may":[286],"be":[287],"deleterious":[288],"combination.":[291]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2157692941","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":11},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":12},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
